← SynDRA
FOSLINANIB
SynDRA canonical compound SYN0025723 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | anticancer agent |
| Indication | neuroendocrine tumors of pancreatic origin (pnet) |
| Disease area | oncology |
Mechanisms of action (all sources)
Cross-references
Synonyms
- CVM-1118
- TRX-818
- CVM-1118 FREE ACID
- TRX-818 FREE ACID
- TRX 818
- ZRPWVAHVWBPHID-UHFFFAOYSA-L
- TRX-818 sodium
- TRX818
- EX-A580
- MolPort-044-567-575
- CVM-1118(CVM1118)
- B5932
- J-690105
- (2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1r,4R)-4-hydroxycyclohexyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrroli dine]-5'-carboxamide
- UNII-2X2DNM7NGX
- 5-yl dihydrogen phosphate
- 2X2DNM7NGX
- 2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-
- 2-(3-Fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl dihydrogen phosphate
- Foslinanib [INN]
- Foslinanib [USAN]
- Foslinanib (USAN/INN)
- Foslinanib [USAN:INN]
- SCHEMBL339272
- CHEMBL1615993
- WHO 10721
- D11639
- 4(1H)-Quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-
- 2-(3-Fluorophenyl)-4-hydroxy-6-methoxyquinolin-5-yl dihydrogen phosphate
- CVM 1118
- foslinanibum
- FMOD phosphate
- RefChem:921791
- CVM1118
- FOSLINANIB [WHO-DD]
- orb1685351
- SCHEMBL30738341
- SCHEMBL31745350
- GTPL11621
Look up FOSLINANIB in the interactive SynDRA portal →